Cancer vaccine advances

A new possible use of iPS cells (see medical and ethical advantages of iPS cells treatment) has been opened up, using them as a type of vaccine against cancer. According to a recent study published in journal CELL (see HERE), autologous iPS cells (i.e. cells from the patient him/herself) can be used to attack the tumor cells and thus try to prevent the development of cancer. According to the director of the research group, Dr Wu, “when we immunized an animal with genetically matching iPS cells, the immune system could be primed to reject the development of tumors in the future”, which means that, “these cells may one day serve as a true patient-specific cancer vaccine”.